To humanize R&D and maintain motivation, biotech leaders bring patients into the company. This practice directly connects scientists with the human impact of their work, grounding the entire team in their shared purpose, especially on difficult days.

The pharmaceutical industry is often misunderstood because it communicates through faceless corporate entities. It could learn from tech's "go direct" strategy, where leaders tell compelling stories. Highlighting the scientists and patient journeys behind breakthroughs could dramatically improve public perception and appreciation.

Beyond nearly doubling survival rates, Immuneering emphasizes concrete quality of life improvements, such as a patient regaining the ability to drive. This patient-centric narrative powerfully demonstrates the drug's real-world impact and differentiates it from therapies with grueling side effects.

A patient on an experimental pancreatic cancer drug emphasized that its greatest benefit was giving her 10 months of a normal life back—working and being a mother and wife. This highlights how quality of life can be as crucial to patients as traditional efficacy endpoints.

The work of founding scientist Dr. Sam Gambhir was deeply personal; he lost his son, himself, and his wife to cancer. This profound loss serves as the company's driving force and enduring mission, transforming the scientific endeavor into a legacy. This demonstrates how personal conviction can fuel progress against intractable problems.

To bridge the psychological gap between direct patient care and the abstract world of pharma R&D, a former clinician visualizes data points not as numbers, but as the real people he once treated. This mental model keeps the patient as the 'North Star' in all decisions.

Jodie Morrison's career was cemented by an early, powerful experience: witnessing a xenotransplant patient go from being wheelchair-bound to running a marathon. This direct link between research and profound human impact hooked her for life.

The biotech industry's messaging to legislators often fails because it focuses on economic contributions. To gain support and combat negative narratives, leaders must shift to "plain speak," using patient stories to humanize their work and focus on their core mission of improving health.

Founder Derek Small's career was imprinted by two key moments: an oncology patient stabilizing for five years on a first dose, and depression patients calling to say his drug "literally changed my life." These direct impacts provided a powerful, mission-driven focus.